The Future of Melanoma Detection

DermTech will revolutionize the detection and diagnosis of dermatologic conditions using a patented non-invasive biopsy technology to analyze gene expression in the skin. Our first product, MelDTect™, will aid in the detection of melanoma, the most serious skin cancer and the most difficult to diagnose. MelDTect™ is a unique test that will improve healthcare and lower the cost. Each year over 3,000,000 surgical biopsies are performed to diagnose 120,000 melanomas. Approximately 10,000 deaths occur annually from melanoma and Dermtech specializes in Melanoma and Skin cancer detection & diagnosis.